Cargando…

The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China

BACKGROUND: This study explored the effect of a continuous mitigation and containment strategy for coronavirus disease 2019 (COVID-19) on five vector-borne diseases (VBDs) in China from 2020 to 2021. METHODS: Data on VBDs from 2015 to 2021 were obtained from the National Health Commission of the Peo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiangyu, Ma, Chenjin, Wang, Lan, Zhao, Na, Liu, Shelan, Xu, Wangli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898061/
https://www.ncbi.nlm.nih.gov/pubmed/35248146
http://dx.doi.org/10.1186/s13071-022-05187-w
_version_ 1784663565220708352
author Guo, Xiangyu
Ma, Chenjin
Wang, Lan
Zhao, Na
Liu, Shelan
Xu, Wangli
author_facet Guo, Xiangyu
Ma, Chenjin
Wang, Lan
Zhao, Na
Liu, Shelan
Xu, Wangli
author_sort Guo, Xiangyu
collection PubMed
description BACKGROUND: This study explored the effect of a continuous mitigation and containment strategy for coronavirus disease 2019 (COVID-19) on five vector-borne diseases (VBDs) in China from 2020 to 2021. METHODS: Data on VBDs from 2015 to 2021 were obtained from the National Health Commission of the People’s Republic of China, and the actual trend in disease activity in 2020–2021 was compared with that in 2015–2019 using a two-ratio Z-test and two proportional tests. Similarly, the estimated trend in disease activity was compared with the actual trend in disease activity in 2020. RESULTS: There were 13,456 and 3684 average yearly cases of VBDs in 2015–2019 and 2020, respectively. This represents a decrease in the average yearly incidence of total VBDs of 72.95% in 2020, from 0.9753 per 100,000 population in 2015–2019 to 0.2638 per 100,000 population in 2020 (t = 75.17, P < 0.001). The observed morbidity rates of the overall VBDs were significantly lower than the predicted rates (47.04% reduction; t = 31.72, P < 0.001). The greatest decline was found in dengue, with a 77.13% reduction (observed rate vs predicted rate: 0.0574 vs. 0.2510 per 100,000; t = 41.42, P < 0.001). Similarly, the average yearly mortality rate of total VBDs decreased by 77.60%, from 0.0064 per 100,000 population in 2015–2019 to 0.0014 per 100,000 population in 2020 (t = 6.58, P < 0.001). A decreasing trend was also seen in the monthly incidence of total VBDs in 2021 compared to 2020 by 43.14% (t = 5.48, P < 0.001). CONCLUSIONS: The results of this study verify that the mobility and mortality rates of VBDs significantly decreased from 2015–2019 to 2020–2021, and that they are possibly associated to the continuous COVID-19 mitigation and contamination strategy implemented in China in 2020–2021. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13071-022-05187-w.
format Online
Article
Text
id pubmed-8898061
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88980612022-03-07 The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China Guo, Xiangyu Ma, Chenjin Wang, Lan Zhao, Na Liu, Shelan Xu, Wangli Parasit Vectors Research BACKGROUND: This study explored the effect of a continuous mitigation and containment strategy for coronavirus disease 2019 (COVID-19) on five vector-borne diseases (VBDs) in China from 2020 to 2021. METHODS: Data on VBDs from 2015 to 2021 were obtained from the National Health Commission of the People’s Republic of China, and the actual trend in disease activity in 2020–2021 was compared with that in 2015–2019 using a two-ratio Z-test and two proportional tests. Similarly, the estimated trend in disease activity was compared with the actual trend in disease activity in 2020. RESULTS: There were 13,456 and 3684 average yearly cases of VBDs in 2015–2019 and 2020, respectively. This represents a decrease in the average yearly incidence of total VBDs of 72.95% in 2020, from 0.9753 per 100,000 population in 2015–2019 to 0.2638 per 100,000 population in 2020 (t = 75.17, P < 0.001). The observed morbidity rates of the overall VBDs were significantly lower than the predicted rates (47.04% reduction; t = 31.72, P < 0.001). The greatest decline was found in dengue, with a 77.13% reduction (observed rate vs predicted rate: 0.0574 vs. 0.2510 per 100,000; t = 41.42, P < 0.001). Similarly, the average yearly mortality rate of total VBDs decreased by 77.60%, from 0.0064 per 100,000 population in 2015–2019 to 0.0014 per 100,000 population in 2020 (t = 6.58, P < 0.001). A decreasing trend was also seen in the monthly incidence of total VBDs in 2021 compared to 2020 by 43.14% (t = 5.48, P < 0.001). CONCLUSIONS: The results of this study verify that the mobility and mortality rates of VBDs significantly decreased from 2015–2019 to 2020–2021, and that they are possibly associated to the continuous COVID-19 mitigation and contamination strategy implemented in China in 2020–2021. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13071-022-05187-w. BioMed Central 2022-03-05 /pmc/articles/PMC8898061/ /pubmed/35248146 http://dx.doi.org/10.1186/s13071-022-05187-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Guo, Xiangyu
Ma, Chenjin
Wang, Lan
Zhao, Na
Liu, Shelan
Xu, Wangli
The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China
title The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China
title_full The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China
title_fullStr The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China
title_full_unstemmed The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China
title_short The impact of COVID-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in China
title_sort impact of covid-19 continuous containment and mitigation strategy on the epidemic of vector-borne diseases in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898061/
https://www.ncbi.nlm.nih.gov/pubmed/35248146
http://dx.doi.org/10.1186/s13071-022-05187-w
work_keys_str_mv AT guoxiangyu theimpactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT machenjin theimpactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT wanglan theimpactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT zhaona theimpactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT liushelan theimpactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT xuwangli theimpactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT guoxiangyu impactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT machenjin impactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT wanglan impactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT zhaona impactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT liushelan impactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina
AT xuwangli impactofcovid19continuouscontainmentandmitigationstrategyontheepidemicofvectorbornediseasesinchina